The trademark application SFA THERAPEUTICS was filed by SFA Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 25, 2022, and it was registered by office on February 1, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceutical preparations for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases
Pharmaceutical products for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases.
The mark was filed in class 42 with following description of goods:
Scientific research for medical purposes in the fields of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases
Research and development of pharmaceuticals for the treatment of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases
Medical and scientific research in the field of pharmaceuticals
Pharmaceutical products development
Medical research
Pharmaceutical testing, pre-clinical research, clinical research, and clinical trials.